Literature DB >> 15906048

A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?

Yuko Tanaka1, Hideaki Yokoo, Takashi Komori, Yoshihisa Makita, Takashi Ishizawa, Takanori Hirose, Michimasa Ebato, Junji Shibahara, Choutatsu Tsukayama, Makoto Shibuya, Yoichi Nakazato.   

Abstract

Mixed neuronal-glial tumors of the central nervous system display a wide spectrum of differentiation. Among them, the papillary glioneuronal tumor (PGNT) is characterized by pseudopapillary structures composed of astroglial cells covering hyalinized vessels, and by neurocytic, ganglioid and ganglion cells. In addition, a "nonspecific" cell type, not similar to either astrocytes or neurocytes, has been recognized since the initial reports. Recently, minigemistocytic cells and a population immunostained by anti-Olig2 antibody have also been recognized in PGNT. Olig2 is a transcription factor that is specific for the cellular phenotype of oligodendrocytes. The aim of this study was to further investigate the histological diversity of PGNT. We examined six cases of PGNT, each of which showed Olig2 immunopositivity. Minigemistocytes were encountered in three cases at close proximity to the Olig2-positive area. Olig2-positive cells were negative for glial fibrillary acidic protein (GFAP) and neuronal nuclear antigen by double immunostaining, and mainly occupied the interpapillary area laterally adjacent to the GFAP-positive cells. They had relatively small, round and vesicular nuclei, and were formerly regarded as neurocytic cells or nonspecific cellular elements. Fluorescence in situ hybridization targeting chromosome 1p failed to demonstrate any deletion. This study disclosed an additional cellular component of PGNT that is characterized by Olig2 positivity, suggestive of oligodendroglial phenotype, and the results also encourage us to investigate oligodendroglial participation in various glioneuronal tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906048     DOI: 10.1007/s00401-005-1018-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

Review 1.  Papillary glioneuronal tumor: case report and review of literature.

Authors:  B Carangelo; U Arrigucci; A Mariottini; L Lavalle; G Muscas; D Branco; L Lippa; G Peri; M Muya; G Costantino; G Tiezzi; D Tacchini; A Maturo
Journal:  G Chir       Date:  2015 Mar-Apr

Review 2.  Papillary glioneuronal tumour: a report of a rare case and review of literature.

Authors:  Surinder Atri; Mehar C Sharma; Chitra Sarkar; Ajay Garg; Ashish Suri
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

3.  Papillary glioneuronal tumor-evidence of stem cell origin with biphenotypic differentiation.

Authors:  Aparna Govindan; A Mahadevan; D I Bhat; A Arivazhagan; Shrijeet Chakraborti; M S Suja; A A Phalguni; S Sampath; B A Chandramouli; S K Shankar
Journal:  J Neurooncol       Date:  2009-04-30       Impact factor: 4.130

Review 4.  Papillary glioneuronal tumor--a rare entity: report of four cases and brief review of literature.

Authors:  Shipra Agarwal; Mehar Chand Sharma; Geetika Singh; Vaishali Suri; Chitra Sarkar; Ajay Garg; Rajinder Kumar; P Sharat Chandra
Journal:  Childs Nerv Syst       Date:  2012-08-07       Impact factor: 1.475

5.  Newly Identified Characteristics and Suggestions for Diagnosis and Treatment of Diffuse Leptomeningeal Glioneuronal/Neuroepithelial Tumors: A Case Report and Review of the Literature.

Authors:  Megan R Lyle; Jaydevsinh N Dolia; Jonathan Fratkin; Todd A Nichols; Betty L Herrington
Journal:  Child Neurol Open       Date:  2015-02-16

6.  Atypical papillary glioneuronal tumor.

Authors:  Jesús Vaquero; Santiago Coca
Journal:  J Neurooncol       Date:  2007-02-07       Impact factor: 4.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.